GCA
Gideon Capital Advisors Portfolio holdings
AUM
$291M
This Quarter Return
+15.03%
1 Year Return
+28.95%
3 Year Return
+37.63%
5 Year Return
+32.15%
10 Year Return
–
AUM
$280M
AUM Growth
+$280M
(+14%)
Cap. Flow
+$19.5M
Cap. Flow
% of AUM
6.99%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
571
New
214
Increased
57
Reduced
81
Closed
219
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$10.9M |
| 2 |
Healthpeak Properties
DOC
|
$4.86M |
| 3 |
Welltower
WELL
|
$4.43M |
| 4 |
Texas Instruments
TXN
|
$4.39M |
| 5 |
PPL Corp
PPL
|
$4.09M |
Top Sells
| 1 |
TWTR
Twitter, Inc.
TWTR
|
$3.29M |
| 2 |
Mastercard
MA
|
$3.24M |
| 3 |
Southern Company
SO
|
$2.52M |
| 4 |
Citigroup
C
|
$2.51M |
| 5 |
Tractor Supply
TSCO
|
$2.44M |
Sector Composition
| 1 | Technology | 23.87% |
| 2 | Financials | 13.49% |
| 3 | Real Estate | 10.64% |
| 4 | Industrials | 10.5% |
| 5 | Utilities | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DISCK
151
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $540K | 0.19% |
21,242
+8,317
| +64% | +$211K |
|
152
Allison Transmission
ALSN
$7.3B
| $539K | 0.19% |
+11,990
| New | +$539K |
|
153
Bio-Rad Laboratories Class A
BIO
$8.06B
| $538K | 0.19% |
+1,761
| New | +$538K |
|
154
Rithm Capital
RITM
$6.57B
| $536K | 0.19% |
31,713
+12,520
| +65% | +$212K |
|
155
Zebra Technologies
ZBRA
$16.1B
| $535K | 0.19% |
2,554
+1,120
| +78% | +$235K |
|
156
Coca-Cola
KO
$297B
| $532K | 0.19% |
11,354
-13,515
| -54% | -$633K |
|
157
Haemonetics
HAE
$2.63B
| $528K | 0.19% |
+6,040
| New | +$528K |
|
158
Carlisle Companies
CSL
$16.5B
| $522K | 0.19% |
+4,259
| New | +$522K |
|
159
Canadian Natural Resources
CNQ
$65.9B
| $520K | 0.19% |
+18,916
| New | +$520K |
|
160
TripAdvisor
TRIP
$2.02B
| $516K | 0.18% |
10,026
-7,449
| -43% | -$383K |
|
161
General Dynamics
GD
$87.3B
| $513K | 0.18% |
3,033
+1,662
| +121% | +$281K |
|
162
Medtronic
MDT
$119B
| $512K | 0.18% |
5,623
+774
| +16% | +$70.5K |
|
163
Assured Guaranty
AGO
$3.91B
| $511K | 0.18% |
+11,490
| New | +$511K |
|
164
Altice USA
ATUS
$1.1B
| $507K | 0.18% |
+23,614
| New | +$507K |
|
165
Flowserve
FLS
$7.02B
| $505K | 0.18% |
11,182
-7,144
| -39% | -$323K |
|
166
Curtiss-Wright
CW
$18B
| $504K | 0.18% |
4,443
+1,518
| +52% | +$172K |
|
167
Huntington Bancshares
HBAN
$26B
| $502K | 0.18% |
+39,594
| New | +$502K |
|
168
Exact Sciences
EXAS
$8.98B
| $501K | 0.18% |
+5,786
| New | +$501K |
|
169
Stellantis
STLA
$27.8B
| $499K | 0.18% |
33,598
+18,491
| +122% | +$275K |
|
170
BioMarin Pharmaceuticals
BMRN
$11.2B
| $495K | 0.18% |
5,578
-3,585
| -39% | -$318K |
|
171
Teradata
TDC
$1.98B
| $495K | 0.18% |
+11,334
| New | +$495K |
|
172
Toro Company
TTC
$8B
| $493K | 0.18% |
7,156
+3,466
| +94% | +$239K |
|
|
GOOS
173
Canada Goose Holdings
GOOS
$1.26B
| $490K | 0.18% |
10,206
-1,289
| -11% | -$61.9K |
|
174
HealthEquity
HQY
$7.72B
| $490K | 0.18% |
+6,630
| New | +$490K |
|
175
Progressive
PGR
$145B
| $490K | 0.18% |
6,800
+800
| +13% | +$57.6K |
|